Search Results - "Gelfand, Jeffrey"
-
1
Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis
Published in Lancet neurology (01-09-2018)“…There have been substantial advances in the recognition and treatment of autoimmune causes of encephalitis, particularly encephalitis associated with…”
Get full text
Journal Article -
2
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review
Published in PloS one (28-04-2016)“…To perform a systematic review of studies using remote physical activity monitoring in neurological diseases, highlighting advances and determining gaps…”
Get full text
Journal Article -
3
Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation
Published in Handbook of clinical neurology (2014)“…The diagnosis of multiple sclerosis (MS) is based on demonstrating evidence of inflammatory-demyelinating injury within the central nervous system that is…”
Get more information
Journal Article -
4
Clofazimine for Babesiosis: Preclinical Data Support a Clinical Trial
Published in The Journal of infectious diseases (18-01-2022)Get full text
Journal Article -
5
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
Published in Neurotherapeutics (01-10-2017)“…Selective depletion of CD20 + B cells by anti-CD20 monoclonal antibodies as monotherapy in multiple sclerosis (MS) profoundly suppresses acute inflammatory…”
Get full text
Journal Article -
6
Dual blockade of CXCL12‐CXCR4 and PD‐1–PD‐L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the tumor microenvironment
Published in The FASEB journal (01-05-2019)“…ABSTRACTBlockade of immune‐checkpoint programmed cell death protein 1 (PD‐1) or programmed cell death ligand 1 can enhance effector T‐cell responses. However,…”
Get full text
Journal Article -
7
Autoimmune Encephalitis Misdiagnosis in Adults
Published in JAMA neurology (01-01-2023)“…Autoimmune encephalitis misdiagnosis can lead to harm. To determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons for…”
Get more information
Journal Article -
8
Cell-surface central nervous system autoantibodies: Clinical relevance and emerging paradigms
Published in Annals of neurology (01-08-2014)“…The recent discovery of several potentially pathogenic autoantibodies has helped identify patients with clinically distinctive central nervous system diseases…”
Get full text
Journal Article -
9
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Published in The Lancet (British edition) (02-12-2017)“…Multiple sclerosis is a degenerative inflammatory disease of the CNS characterised by immune-mediated destruction of myelin and progressive neuroaxonal loss…”
Get full text
Journal Article -
10
Risk of Neuroinflammatory Adverse Events With Tumor Necrosis Factor Inhibitor Treatment
Published in JAMA neurology (01-08-2020)Get more information
Journal Article -
11
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels
Published in Annals of neurology (01-01-2013)“…Objective: To report a novel cell surface autoantigen of encephalitis that is a critical regulatory subunit of the Kv4.2 potassium channels. Methods: Four…”
Get full text
Journal Article -
12
Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Published in The FASEB journal (01-05-2020)“…There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐19). Early anecdotal reports and limited in vitro data led to the…”
Get full text
Journal Article -
13
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
Published in Lancet neurology (01-11-2012)“…Summary Background Microcystic macular oedema (MMO) of the retinal inner nuclear layer (INL) has been identified in patients with multiple sclerosis (MS) by…”
Get full text
Journal Article -
14
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Published in Brain (London, England : 1878) (01-08-2018)“…The mechanisms responsible for the generation of LGI1- or CASPR2-antibodies are unknown. Binks et al. describe two strikingly dichotomous HLA-associations,…”
Get full text
Journal Article -
15
Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment
Published in Neurology : neuroimmunology & neuroinflammation (01-11-2021)“…Although often regarded as a protean illness with myriad clinical and imaging manifestations, neurosarcoidosis typically presents as recognizable syndromes…”
Get full text
Journal Article -
16
The importance of early immunotherapy in patients with faciobrachial dystonic seizures
Published in Brain (London, England : 1878) (01-02-2018)“…Faciobrachial dystonic seizures (FBDS) are the first adult-onset autoantibody-mediated epilepsy. Thompson et al. describe 103 patients with FBDS, and show that…”
Get full text
Journal Article -
17
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
Published in Proceedings of the National Academy of Sciences - PNAS (15-09-2020)“…Central nervous system B cells have several potential roles in multiple sclerosis (MS): secretors of proinflammatory cytokines and chemokines, presenters of…”
Get full text
Journal Article -
18
Risk of Multiple Sclerosis After a Clinically Isolated Syndrome: From Magnetic Resonance Imaging to Oligoclonal Bands to Activated T Cells
Published in JAMA neurology (01-03-2017)Get more information
Journal Article -
19
A clinical approach to diagnosis of autoimmune encephalitis
Published in Lancet neurology (01-04-2016)“…Summary Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune…”
Get full text
Journal Article -
20
Microcystic macular oedema in multiple sclerosis is associated with disease severity
Published in Brain (London, England : 1878) (01-06-2012)“…Macular oedema typically results from blood-retinal barrier disruption. It has recently been reported that patients with multiple sclerosis treated with…”
Get full text
Journal Article